|
⚲
|
| Keyboard |
| Vida Ventures GP III LLC | |
|---|---|
| Firm | Vida Ventures Management Co LLC |
| Address | c/o Vida Ventures 40 Broad Street, Suite 201 Boston, MA 02109 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Vida Ventures Management Co LLC | |||||
| Vida Ventures III-A LP | 021-395296 | Executive Officer | of 750.0 M |
1.6 M | |
| Vida Ventures III LP | 021-395296 | Executive Officer | of 750.0 M |
750.0 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Kyverna Therapeutics Inc KYTX
Series A-1 Redeemable Convertible Preferred Stock · derivative
|
2024-02-12 | Conversion | 4,401,771 | $0.00 | |
|
Kyverna Therapeutics Inc KYTX
Common Stock
|
2024-02-12 | Conversion | 4,523,924 | ||
|
Kyverna Therapeutics Inc KYTX
Common Stock
|
2024-02-12 | Buy | 252,553 | $22.00 | 5,556,166 |
|
Kyverna Therapeutics Inc KYTX
Common Stock
|
2024-02-12 | Buy | 583 | $22.00 | 12,826 |
|
Kyverna Therapeutics Inc KYTX
Series B Redeemable Convertible Preferred Stock · derivative
|
2024-02-12 | Conversion | 7,356,162 | $0.00 | |
|
Kyverna Therapeutics Inc KYTX
Series A-2 Redeemable Convertible Preferred Stock · derivative
|
2024-02-12 | Conversion | 8,830,901 | $0.00 | |
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2022-01-11 | Conversion | 7,684 | ||
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2022-01-11 | Buy | 3,852 | $14.00 | 53,928 |
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2022-01-11 | Conversion | 3,333,245 | ||
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2022-01-11 | Buy | 1,671,148 | $14.00 | 23,396,072 |
|
Vigil Neuroscience Inc VIGL
Series B Preferred Stock · derivative
|
2022-01-11 | Conversion | 9,243,756 | $0.00 | |
|
Vigil Neuroscience Inc VIGL
Series B Preferred Stock · derivative
|
2022-01-11 | Conversion | 21,310 | $0.00 |